Most people blame bad bosses for stalled careers. But some of the biggest slowdowns come from leaders you actually like working for. This piece breaks down the difference between comfort and stretch—and why it’s harder to see when you’re in it.

A warming job market changes behavior before it changes outcomes. This article examines how even modest signs of improvement can reopen stalled decisions, expose hidden retention risk, and deepen frustration for job seekers when the story of recovery moves faster than the reality.

Most goals fail before execution begins—not because they’re wrong, but because subtraction never happened. This article examines why leaders absorb the cost of unspoken tradeoffs, and how prioritizing what comes off the table is the real lever for execution.

Your title says Senior Director. Your scope says something else. Some environments starve capability growth while appearing to reward you. Here's how to tell the difference.

When belief in the mission remains but the career path doesn't, what do you do? A framework for thinking about staying with strategy—not fear.

In volatile industries like biopharma, staying put might seem like a smart bet, but job hugging can quietly erode your visibility, growth and future opportunities.

Transparency doesn’t drive people away—it attracts the right ones. In this bold take, Angela Justice urges biopharma leaders to stop sugarcoating the journey and start telling the whole truth.

She turned down a recruiter two weeks before being laid off. This article unpacks why loyalty without leverage is a liability—and how to stay strategic without guilt.

Unfair feedback stings because you care. This article unpacks why the gap between intent and impact matters more than fairness—and how to turn critique into traction.

Three exits. Three very different outcomes. One disappeared. One burned bridges. One built them. Why your last impression matters more than your first—and how to leave well.

You raised the alarm. Leadership heard you. Nothing changed. This article unpacks why being right isn't enough—and three steps to turn insights into action.

She felt relieved to still have her job—but that relief quickly turned to guilt. Then panic. This is survivor syndrome, and it's hitting biopharma teams hard. Three steps to regain control.